Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Diagnostic Medical SystemsXPAR:ALDMS 66 Equity-to-Asset is 0.31 as of Dec. 2025, which is 14% below its 10-year median of 0.36. GuruFocus rates XPAR:ALDMS with a GF Score™ of 66/100 and a GF Value™ of €1.13 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Diagnostic Medical Systems ranks worse than 83.08% on this metric.
The historical rank and industry rank for Diagnostic Medical Systems's Equity-to-Asset or its related term are showing as below:
XPAR:ALDMS'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.24 Med: 0.36 Max: 0.59
Current: 0.31
During the past 13 years, the highest Equity to Asset Ratio of Diagnostic Medical Systems was 0.59. The lowest was 0.24. And the median was 0.36.
XPAR:ALDMS's Equity-to-Asset is ranked worse than 83.08% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs XPAR:ALDMS: 0.31
Diagnostic Medical Systems (XPAR:ALDMS) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Diagnostic Medical Systems Equity-to-Asset Related Terms
Diagnostic Medical Systems Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALDMS vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Diagnostic Medical Systems's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostic Medical Systems Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Diagnostic Medical Systems's Equity-to-Asset falls into.
Diagnostic Medical Systems Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Diagnostic Medical Systems's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostic Medical Systems (XPAR:ALDMS) has a Equity-to-Asset of 0.31 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Diagnostic Medical Systems and its competitors. This is 14% below median its historical median of 0.36. Over the past decade, Diagnostic Medical Systems' Equity-to-Asset has ranged from 0.24 to 0.59. According to the industry distribution chart, Diagnostic Medical Systems ranks #707 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 83.1%.
Is Diagnostic Medical Systems' Equity-to-Asset too high?
Diagnostic Medical Systems' current Equity-to-Asset of 0.31 is 14% below median its 10-year median of 0.36. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 0.59. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Diagnostic Medical Systems' value of 0.31 is 51.6% below this industry median. Based on the distribution chart, Diagnostic Medical Systems ranks #707 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Diagnostic Medical Systems has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #707 out of 851 companies for Equity-to-Asset. This places Diagnostic Medical Systems in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Diagnostic Medical Systems' value of 0.31 is 51.6% below this benchmark. Historically, Diagnostic Medical Systems' own Equity-to-Asset has ranged from 0.24 to 0.59 over the past decade. While the company's 10-year median is 0.36 vs. the industry median of 0.64, Diagnostic Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnostic Medical Systems's current Equity-to-Asset of 0.31 is 51.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Diagnostic Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostic Medical Systems's current Equity-to-Asset is 0.31, which is 14% below median its own 10-year median of 0.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (XPAR:ALDMS) is currently considered Modestly Undervalued. The stock's GF Value™ is €1.13, compared to a current price of €1.02 — trading 10.2% below its estimated fair value. The current Equity-to-Asset is 0.31, which is 14% below median its 10-year median of 0.36 and 51.6% below the Medical Devices & Instruments industry median of 0.64. Diagnostic Medical Systems' overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Diagnostic Medical Systems (XPAR:ALDMS), the current Equity-to-Asset is 0.31 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be undervalued.
The current stock price of €1.02 is trading 10.2% below its estimated GF Value™ of €1.13.
GuruFocus considers Diagnostic Medical Systems to be Modestly Undervalued.
Key valuation signals for XPAR:ALDMS:
Equity-to-Asset: 0.31 (14% below median its 10-year median of 0.36)
GF Value™: €1.13 vs. price of €1.02 (10.2% below fair value)
Industry Position: 51.6% below the Medical Devices & Instruments median (#707 of 851)
No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
66GF Score
Get the complete analysis for XPAR:ALDMS
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALDMS has been successfully added to your 
